Back to News
Market Impact: 0.24

You Can Do Better Than Tesla. Buy Micron Instead.

Source: The Motley Fool

Artificial IntelligenceAutomotive & EVCompany FundamentalsAnalyst EstimatesAnalyst InsightsInvestor Sentiment & Positioning

The article favors Micron over Tesla, citing Micron's 31% year-over-year fiscal Q4 2026 revenue growth, 33% GAAP net-income growth, and roughly 81% operating margin, versus Tesla's 23% revenue growth, 5% net-income decline, and 269bp margin compression to 1.4%. Tesla trades at about 345x trailing earnings and 171x forward earnings, more than 14x its Consumer Discretionary sector P/E average of 24.4, while Micron trades at 14x trailing earnings despite an almost 6x share-price increase over the past year. Analysts' average targets imply about 38% upside for Micron versus 9% for Tesla, with 80% of Micron analysts rating it a strong buy and none recommending a sale.

Analysis

The actionable setup is relative, not an outright endorsement of MU after its sharp run: long MU/short TSLA expresses a near-term earnings-quality divergence. MU’s upside depends on HBM mix and contract-pricing durability, which can drive estimate revisions and multiple support over the next 1-3 months; TSLA’s valuation requires credible evidence that non-auto businesses can offset auto gross-margin pressure. The article’s reported 81% operating margin for MU is not economically plausible for a memory manufacturer and must be verified against the filing before using any margin-based valuation conclusion.

Second-order risk for MU is that AI memory tightness eventually induces capacity additions from Samsung Electronics and SK Hynix, turning an earnings-upcycle narrative into a conventional memory-cycle peak. The key 6-18 month question is whether HBM remains supply-constrained while leading-edge DRAM capacity is redirected away from commodity products; if not, MU’s low headline P/E can prove cyclical rather than cheap. For TSLA, a weaker vehicle pricing environment would also pressure suppliers and EV peers such as RIVN and LCID, but TSLA can re-rate sharply higher if autonomy monetization, energy-storage growth, or a material China demand rebound becomes measurable rather than aspirational.

Consensus likely overstates the cleanliness of the MU-versus-TSLA comparison: MU’s earnings are highly sensitive to memory ASPs and inventory normalization, while TSLA retains option value that conventional P/E screens undercapture. Therefore, the pair should be sized as a catalyst trade through the next two reporting cycles, not as a permanent structural short of TSLA. A reversal in HBM pricing, MU inventory days, or TSLA forward delivery/gross-margin guidance would matter more than analyst target-price changes.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.38

Ticker Sentiment

MU0.76
NVDA0.05
TSLA-0.78

Key Decisions for Investors

  • Initiate a 1-3 month beta-adjusted long MU / short TSLA pair only after verifying MU’s reported segment margins, HBM revenue mix, and forward EPS estimates from primary filings. Target 15-20% relative outperformance; stop if MU cuts forward gross-margin guidance or TSLA raises delivery and automotive-margin outlook.
  • Use MU call spreads rather than unhedged stock for the next earnings catalyst if HBM contract-price data remains firm: buy 3-month near-ATM calls and sell strikes 15-20% higher. This limits exposure to a broad semiconductor de-rating while retaining upside from estimate revisions.
  • Maintain TSLA downside exposure via 3-6 month put spreads rather than naked shorts, with strikes centered around the next material support level. Cover if autonomous-driving, robotaxi, or energy-storage disclosures produce quantifiable revenue/backlog evidence sufficient to lift forward earnings expectations.
  • Monitor SK Hynix and Samsung memory-capex commentary, DRAM spot/contract pricing, and MU inventory metrics as falsification alerts. Any broad easing in HBM lead times or aggressive capacity-expansion guidance should reduce MU exposure before the market reclassifies its earnings as cycle-peak profits.

More News

From AllMind Research

Browse all research